tirzepatide gip & glp-1 Frontiers Tirzepatide | DirectMeds

*Correspondence: Yulan Li, [email protected] These authors have contributed equally to this work and share first authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Although these differences make indirect comparisons of early efficacy between treatments challenging, the dose escalation scheme may become a clinically relevant factor when selecting agents for patients with varied glycaemic control needs

While moderate drinking may be harmless for many, heavy or chronic alcohol use can damage the liver, heart, immune system, and brain

Millions of people are living with arthritis, stuck in a cycle of temporary relief and long-term damage